Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John J Brewington

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
International Journal of Molecular Sciences|April 30, 2021
Nasal Epithelial Cell-Based Models for Individualized Study in Cystic FibrosisDuncan E Keegan, John J Brewington
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 4, 2026
Who will win the race for the first CFTR gene replacement therapy?John J Brewington, Marcus A Mall, Yutaka Maeda
Clinics in Chest Medicine|November 7, 2022
Novel Applications of Biomarkers and Personalized Medicine in Cystic FibrosisJennifer S Guimbellot, David P Nichols, John J Brewington
Expert Review of Respiratory Medicine|November 20, 2015
Lumacaftor alone and combined with ivacaftor: preclinical and clinical trial experience of F508del CFTR correctionJohn J Brewington, Gary L McPhail, John P Clancy
American Journal of Respiratory and Critical Care Medicine|October 16, 2015
Update in Pediatric Lung Disease 2014Christopher M Siracusa, John J Brewington, Justin C Brockbank, et al.
The European Respiratory Journal|March 23, 2018
Personalised CFTR pharmacotherapeutic response testing and therapy of cystic fibrosisCormac McCarthy, John J Brewington, Beth Harkness, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 10, 2021
When CFSPID becomes CFDaniella Ginsburg, Choo Phei Wee, Maria Carmen Reyes, et al.
Ebiomedicine|January 8, 2022
CRISPRi links COVID-19 GWAS loci to LZTFL1 and RAVER1Iris M Fink-Baldauf, William D Stuart, John J Brewington, et al.
Pediatric Pulmonology|December 30, 2022
Gradual increase in sweat chloride concentration is associated with a higher risk of CRMS/CFSPID to CF reclassificationDanieli B Salinas, Daniella K Ginsburg, Choo Phei Wee, et al.
Environmetrics|March 9, 2026
Spike and Slab Regression for Nonstationary Gaussian Linear Mixed Effects Modeling of Rapid Disease ProgressionEmrah Gecili, Cole Brokamp, Özgür Asar, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
International Journal of Molecular Sciences|April 30, 2021
Nasal Epithelial Cell-Based Models for Individualized Study in Cystic FibrosisDuncan E Keegan, John J Brewington
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 4, 2026
Who will win the race for the first CFTR gene replacement therapy?John J Brewington, Marcus A Mall, Yutaka Maeda
Clinics in Chest Medicine|November 7, 2022
Novel Applications of Biomarkers and Personalized Medicine in Cystic FibrosisJennifer S Guimbellot, David P Nichols, John J Brewington
Expert Review of Respiratory Medicine|November 20, 2015
Lumacaftor alone and combined with ivacaftor: preclinical and clinical trial experience of F508del CFTR correctionJohn J Brewington, Gary L McPhail, John P Clancy
American Journal of Respiratory and Critical Care Medicine|October 16, 2015
Update in Pediatric Lung Disease 2014Christopher M Siracusa, John J Brewington, Justin C Brockbank, et al.
The European Respiratory Journal|March 23, 2018
Personalised CFTR pharmacotherapeutic response testing and therapy of cystic fibrosisCormac McCarthy, John J Brewington, Beth Harkness, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 10, 2021
When CFSPID becomes CFDaniella Ginsburg, Choo Phei Wee, Maria Carmen Reyes, et al.
Ebiomedicine|January 8, 2022
CRISPRi links COVID-19 GWAS loci to LZTFL1 and RAVER1Iris M Fink-Baldauf, William D Stuart, John J Brewington, et al.
Pediatric Pulmonology|December 30, 2022
Gradual increase in sweat chloride concentration is associated with a higher risk of CRMS/CFSPID to CF reclassificationDanieli B Salinas, Daniella K Ginsburg, Choo Phei Wee, et al.
Environmetrics|March 9, 2026
Spike and Slab Regression for Nonstationary Gaussian Linear Mixed Effects Modeling of Rapid Disease ProgressionEmrah Gecili, Cole Brokamp, Özgür Asar, et al.
Pageof 3